Synthesis of several derivatives of methylthiophosphonic acids, cholinesterase inhibitors

Author(s):  
A. A. Abduvakhabov ◽  
N. N. Godovikov ◽  
M. I. Kabachnik
2017 ◽  
Vol 350 (8) ◽  
pp. 1700076 ◽  
Author(s):  
Suchita Prasad ◽  
Bipul Kumar ◽  
Shiv Kumar ◽  
Karam Chand ◽  
Shashank S. Kamble ◽  
...  

1983 ◽  
Vol 52 (10) ◽  
pp. 918-930 ◽  
Author(s):  
Abid S Sadykov ◽  
D N Dalimov ◽  
Nikolai N Godovikov

Molecules ◽  
2020 ◽  
Vol 25 (21) ◽  
pp. 4872
Author(s):  
Tena Čadež ◽  
Ana Grgičević ◽  
Ramiza Ahmetović ◽  
Danijela Barić ◽  
Nikolina Maček Hrvat ◽  
...  

A library of amine, oxime, ether, epoxy and acyl derivatives of the benzobicyclo[3.2.1]octene were synthesized and evaluated as inhibitors of both human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The majority of the tested compounds exhibited higher selectivity for BChE. Structural adjustment for AChE seems to have been achieved by acylation, and the furan ring opening of furo-benzobicyclo[3.2.1]octadiene results for compound 51 with the highest AChE affinity (IC50 = 8.3 µM). Interestingly, its analogue, an oxime ether with a benzobicyclo[3.2.1]-skeleton, compound 32 was one of the most potent BChE inhibitors in this study (IC50 = 31 µM), but not as potent as endo-43, an ether derivative of the benzobicyclo[3.2.1]octene with an additional phenyl substituent (IC50 = 17 µM). Therefore, we identified several cholinesterase inhibitors with a potential for further development as potential drugs for the treatment of neurodegenerative diseases.


2012 ◽  
Vol 55 (23) ◽  
pp. 10700-10715 ◽  
Author(s):  
Inessa Yanovsky ◽  
Efrat Finkin-Groner ◽  
Andrey Zaikin ◽  
Lena Lerman ◽  
Hila Shalom ◽  
...  

2009 ◽  
Vol 30 (8) ◽  
pp. 1195-1203 ◽  
Author(s):  
Yu-fang Shi ◽  
Hai-yan Zhang ◽  
Wei Wang ◽  
Yan Fu ◽  
Yu Xia ◽  
...  

PeerJ ◽  
2016 ◽  
Vol 4 ◽  
pp. e2140 ◽  
Author(s):  
Yao Chen ◽  
Yaoyao Bian ◽  
Yuan Sun ◽  
Chen Kang ◽  
Sheng Yu ◽  
...  

Inhibition of acetylcholinesterase (AChE) using small molecules is still one of the most successful therapeutic strategies in the treatment of Alzheimer’s disease (AD). Previously we reported compound T5369186 with a core of quinolone as a new cholinesterase inhibitor. In the present study, in order to identify new cores for the designing of AChE inhibitors, we screened different derivatives of this core with the aim to identify the best core as the starting point for further optimization. Based on the results, we confirmed that only 4-aminoquinoline (compound 04 and 07) had cholinesterase inhibitory effects. Considering the simple structure and high inhibitory potency against AChE, 4-aminoquinoline provides a good starting core for further designing novel multifunctional AChEIs.


2013 ◽  
Vol 21 (7) ◽  
pp. 1735-1748 ◽  
Author(s):  
Aleš Imramovský ◽  
Vladimír Pejchal ◽  
Šárka Štěpánková ◽  
Katarína Vorčáková ◽  
Josef Jampílek ◽  
...  

2014 ◽  
Vol 13 (5) ◽  
pp. 739 ◽  
Author(s):  
MA Abbasi ◽  
S Ahmad ◽  
A Rehman ◽  
S Rasool ◽  
KM Khan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document